Pulmonary Arterial Hypertension (PAH)
53 clinical trials · Condition
◉ Watch Pulmonary Arterial Hypertension (PAH)
| Record | Firm | Date |
|---|---|---|
| a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China (NCT05546125) | Pfizer Pharmaceuticals Ltd. | 2021-12-23 |
| (RIGHT HEART III Study - Right Ventricular Hemodynamic Evaluation and Response to Treatment) (NCT03362047) | University of Giessen | 2018-03-01 |
| ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy (NCT03145298) | Cedars-Sinai Medical Center | 2017-10-01 |
| The PAH Disability and Bothersomeness Questionnaire (NCT03235401) | Association de Recherche en Physiopathologie Respiratoire | 2017-06-16 |
| Right Ventricular Pulmonary Vascular Interaction in Pulmonary Hypertension (NCT03523910) | University of Wisconsin, Madison | 2012-04-25 |
| Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients (NCT00586794) | Competence Network for Congenital Heart Defects | 2007-12-01 |
| COMPERA / COMPERA-KIDS (NCT01347216) | Technische Universität Dresden | 2007-07-01 |
Track Pulmonary Arterial Hypertension (PAH) automatically
Every clearance here is in the API, with alerts when new ones post.